RWTH Aachen University or Rheinisch-Westfälische Technische Hochschule Aachen is an elite German public research university located in Aachen, North Rhine-Westphalia, Germany. With more than 47,000 students enrolled in 144 study programs, it is the largest technical university in Germany.

During the past decade, RWTH Aachen University conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 2 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 1 clinical trials were completed. i.e. 7.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "RWTH Aachen University" #1 sponsor was "RWTH Aachen University" with 10 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Agennix" with 1 trials sponsored, "Azienda Ospedaliera di Padova" with 1 trials sponsored and "CENTOGENE GmbH Rostock" with 1 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "RWTH Aachen University" #1 collaborator was "RWTH Aachen University" with 2 trials as a collaborator, "Acute Leukemia French Association" with 1 trials as a collaborator, "Auckland District Health Board" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cairns Hospital" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "RWTH Aachen University" are "Surgery" (3 trials), "Anemia" (2 trials), "Coronary Artery Disease" (2 trials), "Acute Kidney Injury" (1 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "RWTH Aachen University" in a lesser frequency.

Most popular intervention types in "RWTH Aachen University" are "Drug" (15 trials), "Device" (6 trials), "Other" (5 trials), "Diagnostic Test" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ACURATE TA™ Transapical Aortic Bioprosthesis" (1 trials), "Amisulpride" (1 trials), "Assessment of systemic inflammation" (1 trials) and "Assessments of the sympathetic nerve activity axis" (1 trials). Other intervention names were less common.

The vast majority of trials in "RWTH Aachen University" are 34 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "RWTH Aachen University". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in RWTH Aachen University, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in RWTH Aachen University, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".

RWTH Aachen University has several departments that took part in Clinical trials: "Department of Medicine, Division of Cardiology, Pulmonology and Vascular Medicine" - 13 trials, "Department of Surgery, University Hospital Aachen" - 5 trials, "Department of Internal Medicine I RWTH Aachen University Hospital" - 4 trials, "Department of Dermatology and Allergology, Medical faculty of the RWTH Aachen" - 2 trials